Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.

Contraception - 1 Oct 2001

Endrikat J, Noah M, Gerlinger C, Bannemerschult R, Junge W, Ruebig A, Schmidt W, Düsterberg B

Abstract excerpt

The evaluation of the study was of the impact of oral contraceptive (OC) use on activated protein C (APC-resistance). Eight hundred eighteen young fertile women were screened for a study designed to compare three different marketed OC preparations. The women could have used either other oral contraceptive preparations before switching to the study medications (switchers) or were not using hormonal contraceptives...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Adolescent

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to APC gene

Share to Mutation

Share to Polymerase Chain Reaction

Share to Protein C

Share to Venous Thrombosis

Source

Identifiers

PMID: 11747870
DOI: 10.1016/s0010-7824(01)00253-0

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.PMID 11747870Read ↗

Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro-progestins.Semantic proximity Read ↗

Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.Semantic proximity Read ↗

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.Semantic proximity Read ↗

The VITA project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Vicenza Thrombophilia and Atherosclerosis.Semantic proximity Read ↗

Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.Semantic proximity Read ↗

[Public health economic evaluation of screening for APC resistance (Leiden mutation) in new oral contraceptive users].Semantic proximity Read ↗

APC resistance and third-generation oral contraceptives: Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease.Semantic proximity Read ↗

Proposal for objective evaluation of the performance of various functional APC-resistance tests in genotyped patients.Semantic proximity Read ↗

Determinants of the APTT- and ETP-based APC sensitivity tests.Semantic proximity Read ↗

Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.Semantic proximity Read ↗

Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients.Semantic proximity Read ↗

Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.